| Line Item | 2025-07-31 | Y/Y |
|---|---|---|
| Revenue | $917K | +44.0% |
| R&D Expense | $12.8M | +207.5% |
| SG&A Expense | $13.8M | +55.6% |
| Operating Income | -$29.2M | +71.6% |
| Interest Expense | $658K | +165.3% |
| Pre-tax Income | -$33.2M | +50.6% |
| Income Tax | -$2.6M | +4.7% |
| Net Income | -$30.5M | +11.3% |
| EPS (Basic) | -$1.04 |
| Line Item | 2025-07-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $52.8M | +1872.7% |
| Accounts Receivable | $627K | +47.2% |
| Inventory | $281K | — |
| Current Assets | $56.7M | -21.8% |
| Total Assets | $114.1M | +17.8% |
| Current Liabilities | $11.6M | +54.4% |
| Total Liabilities | $15.7M | +48.8% |
| Line Item | 2025-07-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.9M | -142.6% |
| Capital Expenditures | $4K | -97.2% |
| Investing Cash Flow | $44.0M | +507.0% |
| Financing Cash Flow | $24.8M | — |
| Free Cash Flow | -$18.9M | -138.2% |
| +28.3% |
| EPS (Diluted) | -$1.04 | +28.3% |
| Stockholders' Equity |
| $94.4M |
| +14.9% |